This page is that in the long run, the involvement of organ damage can be significantly reduced, and the annual growth rate of the involvement will slow down. It concluded that the probability is 61% lower. It is two trials, one is systemic lupus erythematosus, the other is lupus kidney, and the following is the presentation of lupus kidney. This is the main data. Renal function improved in 24 weeks and the risk of severe recurrence was reduced by 40% or more. This is also lupus. Renal, it can improve renal function as early as the 24th week of treatment, and this state can continue. <br>1: Got it.
正在翻译中..